BIOACTIVE BIPHASIC COMPOSITIONS
    4.
    发明公开

    公开(公告)号:US20240269153A1

    公开(公告)日:2024-08-15

    申请号:US18565033

    申请日:2022-05-27

    发明人: C. Russell THOMAS

    摘要: Various aspects of this disclosure relate to excipients comprising a solid phase and a liquid phase, wherein the solid phase has a surface-area-to-volume ratio of at least 500 per meter, which improves the bioavailability and pharmacokinetics of various hydrophobic ingredients. Compositions comprising such excipients can be utilized to disperse a hydrophobic ingredient in a beverage, which improves the bioavailability and pharmacokinetics of the dispersed hydrophobic ingredient.

    Liver Vitality
    6.
    发明公开
    Liver Vitality 审中-公开

    公开(公告)号:US20240197801A1

    公开(公告)日:2024-06-20

    申请号:US18083477

    申请日:2022-12-17

    申请人: Porche Price

    摘要: This disclosure relates to administering, manufacturing, and composing oral formulations to treat and prevent fatty liver disease, liver dysfunction, and hepatic impairment. The treatment and prevention may be one or both liver dysfunction-related primary and secondary diseases. The herbal blend may be made of one or more artichokes, dandelion, milk thistle, alpha-lipoic acid, and turmeric. The enzyme blend may be made of one or more isolated enzymes from amylase, glucoamylase, protease 4.5, protease 6, protease 3, neutral protease, peptidase, papain, alpha-galactosidase, acid maltase, cellulase, pectinase, protease inhibitor 6.0, lipase, lactase, bromelain, cellulase, xylanase, beta-glucanase, invertase, hemicellulose, etc., and any combination thereof. The formulation may be in two compartments, the outer and the inner—the outer compartment has the herbal blend and the internal has the enzyme blend. The inner compartment may be gastric acid resistant.